1
|
Chrysostomou PP, Freeman EL, Murphy MM, Pereira R, Esdaile DJ, Keohane P. A toxicological assessment of spermidine trihydrochloride produced using an engineered strain of Saccharomyces cerevisiae. Food Chem Toxicol 2024; 184:114428. [PMID: 38163454 DOI: 10.1016/j.fct.2023.114428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2023] [Accepted: 12/26/2023] [Indexed: 01/03/2024]
Abstract
Spermidine is a polyamine consumed in the diet, endogenously biosynthesized in most cells, and produced by the intestinal microbiome. A variety of foods contribute to intake of spermidine along with other polyamines. Spermidine trihydrochloride (spermidine-3HCl) of high purity can be produced using an engineered strain of Saccharomyces cerevisiae. Spermidine has a demonstrated history of safe use in the diet; however, limited information is available in the public literature to assess the potential toxicity of spermidine-3HCl. To support a safety assessment for this spermidine-3HCl as a dietary source of spermidine, authoritative guideline and good laboratory practice (GLP) compliant in vitro genotoxicity assays (bacterial reverse mutation and mammalian micronucleus assays) and a 90-day oral (dietary) toxicity study in rats were conducted with spermidine-3HCl. Spermidine-3HCl was non-genotoxic in the in vitro assays, and no adverse effects were reported in the 90-day oral toxicity study up to the highest dose tested, 12500 ppm, equivalent to 728 mg/kg bw/day for males and 829 mg/kg bw/day for females. The subchronic no observed adverse effect level (NOAEL) is 728 mg/kg bw/day.
Collapse
Affiliation(s)
- Paola P Chrysostomou
- Exponent Inc., Center for Chemical Regulation and Food Safety, 1150 Connecticut Ave, NW, Suite 1100, Washington, DC, 20036, USA.
| | - Elaine L Freeman
- Exponent Inc., Center for Chemical Regulation and Food Safety, 1150 Connecticut Ave, NW, Suite 1100, Washington, DC, 20036, USA
| | - Mary M Murphy
- Exponent Inc., Center for Chemical Regulation and Food Safety, 1150 Connecticut Ave, NW, Suite 1100, Washington, DC, 20036, USA
| | - Rui Pereira
- Chrysea Labs Lda, Parque Tecnológico de Cantanhede Nucleo 4 Lote 2, 3060-197, Cantanhede, Portugal
| | - David J Esdaile
- Charles River Laboratories Hungary, Kft. H-8200 Veszprém, Szabadságpuszta, Hrsz. 028/1., Hungary
| | - Patrick Keohane
- Chrysea Labs Lda, Parque Tecnológico de Cantanhede Nucleo 4 Lote 2, 3060-197, Cantanhede, Portugal
| |
Collapse
|
2
|
Freeman EL, Ward R, Murphy MM, Wang T, Ryder J. Comprehensive safety assessment of serendipity berry sweet protein produced from Komagataella phaffii. Regul Toxicol Pharmacol 2024; 147:105562. [PMID: 38190935 DOI: 10.1016/j.yrtph.2024.105562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 11/29/2023] [Accepted: 01/03/2024] [Indexed: 01/10/2024]
Abstract
Serendipity berry plant (Dioscoreophyllum cumminsii (Stapf) Diels) is the source of a naturally sweet protein referred to as monellin. The safety of serendipity berry sweet protein (SBSP) containing single polypeptide monellin (MON) expressed in Komagataella phaffii (formerly Pichia pastoris) and produced via precision fermentation was examined comprehensively through assessments of in vitro and in silico protein digestion, in silico allergenicity, in vitro genotoxicity (reverse mutation and mammalian micronucleus assays), and 14-day and 90-day oral (dietary) toxicity studies in rats. There was no indication of allergenicity for SBSP in the in silico analyses. Results from both in vitro and in silico protein digestibility assessments indicated that SBSP is digested upon ingestion and would therefore be unlikely to pose a toxigenic or allergenic risk to consumers. SBSP was non-genotoxic in in vitro assays and showed no adverse effects in the 14-day or 90-day toxicity studies up to the highest dose tested. The 90-day toxicity study supports a NOAEL for SBSP of 1954 mg/kg bw/day, which corresponds to a NOAEL for MON of 408 mg/kg bw/day.
Collapse
Affiliation(s)
- Elaine L Freeman
- Exponent Inc., Center for Chemical Regulation and Food Safety, 1150 Connecticut Ave NW, Suite 1100, Washington, DC, 20036, USA.
| | - Rachel Ward
- Exponent Inc., Center for Chemical Regulation and Food Safety, 1150 Connecticut Ave NW, Suite 1100, Washington, DC, 20036, USA
| | - Mary M Murphy
- Exponent Inc., Center for Chemical Regulation and Food Safety, 1150 Connecticut Ave NW, Suite 1100, Washington, DC, 20036, USA
| | - Tina Wang
- Oobli, Inc., 202 Cousteau Place, Suite 210, Davis, CA, 95618, USA
| | - Jason Ryder
- Oobli, Inc., 202 Cousteau Place, Suite 210, Davis, CA, 95618, USA; Department of Chemical and Biomolecular Engineering, University of California, Berkeley, Berkeley, CA, 94720, USA.
| |
Collapse
|
3
|
Thiffault C, Freeman EL, Williams GM, Tran NL. Lack of genotoxicity potential and safety assessment of 4-(2-hydroxyethyl) morpholine present as an impurity in pharmaceuticals and nutritional supplements. Food Chem Toxicol 2024; 184:114352. [PMID: 38081535 DOI: 10.1016/j.fct.2023.114352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 11/06/2023] [Accepted: 12/05/2023] [Indexed: 12/23/2023]
Abstract
4-(2-Hydroxyethyl) morpholine (HEM) is widely used as a building block of macromolecules in the manufacture of pharmaceuticals and dietary supplements and could remain as an impurity in the finished products. An evaluation of HEM was conducted to identify endpoints that could be used to determine the point-of-departure (POD) for use in assessing the potential risk from exposure to HEM. No oral repeated dose toxicological studies of appropriate duration were found for HEM. Therefore, suitable analogue(s) were identified. Although oral repeated dose studies were available for the analogues, the studies were not of sufficient duration for use in the assignment of a POD for risk evaluation. Accordingly, the Threshold of Toxicological Concern (TTC) approach, which proposes that a de minimis value can be derived to qualitatively assess risk, was considered for HEM. To determine the appropriate TTC approach (genotoxic or non-genotoxic), the genotoxicity of HEM and its analogues were evaluated. The weight of the evidence indicated that HEM, and the appropriate analogues, are not genotoxic. Considering the chemical structure of HEM, the non-genotoxic Cramer class III TTC value of 1.5 μg/kg bw/day was determined to be appropriate for use in safety assessment of HEM as an impurity in products intended for human consumption.
Collapse
Affiliation(s)
- Christine Thiffault
- Exponent Center for Chemical Regulation and Food Safety, Washington, DC, USA.
| | - Elaine L Freeman
- Exponent Center for Chemical Regulation and Food Safety, Washington, DC, USA
| | - Gary M Williams
- Department of Pathology, New York Medical College Valhalla, NY, USA
| | - Nga L Tran
- Exponent Center for Chemical Regulation and Food Safety, Washington, DC, USA
| |
Collapse
|
4
|
Staveley JP, Freeman EL, McArdle ME, Ortego LS, Coady KK, Bone A, Lagadic L, Weltje L, Weyers A, Wheeler JR. Current testing programs for pesticides adequately capture endocrine activity and adversity for protection of vertebrate wildlife. Integr Environ Assess Manag 2023. [PMID: 36597818 DOI: 10.1002/ieam.4732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Revised: 12/22/2022] [Accepted: 12/23/2022] [Indexed: 06/17/2023]
Abstract
The toxicity and ecotoxicity of pesticide active ingredients are evaluated by a number of standardized test methods using vertebrate animals. These standard test methods are required under various regulatory programs for the registration of pesticides. Over the past two decades, additional test methods have been developed with endpoints that are responsive to endocrine activity and subsequent adverse effects. This article examines the available test methods and their endpoints that are relevant to an assessment of endocrine-disrupting properties of pesticides. Furthermore, the article highlights how weight-of-evidence approaches should be applied to determine whether an adverse response in (eco)toxicity tests is caused by an endocrine mechanism of action. The large number of endpoints in the current testing paradigms for pesticides make it unlikely that endocrine activity and adversity is being overlooked. Integr Environ Assess Manag 2023;00:1-21. © 2023 Bayer CropScience and The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Collapse
Affiliation(s)
| | | | | | - Lisa S Ortego
- Bayer Crop Science, Environmental Safety, Chesterfield, Missouri, USA
| | - Katherine K Coady
- Bayer Crop Science, Environmental Safety, Chesterfield, Missouri, USA
| | - Audrey Bone
- Bayer Crop Science, Environmental Safety, Chesterfield, Missouri, USA
| | - Laurent Lagadic
- Bayer AG, Crop Science, Environmental Safety, Monheim am Rhein, Germany
| | - Lennart Weltje
- BASF SE, Agricultural Solutions-Ecotoxicology, Limburgerhof, Germany
| | - Arnd Weyers
- Bayer AG, Crop Science, Environmental Safety, Monheim am Rhein, Germany
| | | |
Collapse
|
5
|
Taylor AA, Freeman EL, van der Ploeg MJC. Regulatory developments and their impacts to the nano-industry: A case study for nano-additives in 3D printing. Ecotoxicol Environ Saf 2021; 207:111458. [PMID: 33254383 DOI: 10.1016/j.ecoenv.2020.111458] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Revised: 10/01/2020] [Accepted: 10/03/2020] [Indexed: 06/12/2023]
Abstract
Nanotechnology has increasing applications in numerous markets, particularly in additive processing (3D printing) and manufacturing, which is important for consumer products, medical devices, construction, and general research and development across many other industries. Nanomaterials are desirable in many products due to their unique properties, but those same properties have made evaluating the risk and regulation of these materials challenging. For risk-based regulations, new applications and nanomaterials should be assessed for both human and environmental hazards and exposure to ensure protection. In general, many risk assessments to date have focused on the non-nano versions of chemicals. The lack of guidance on assessing the hazard and exposure of nanomaterials in 3D printing is apparent, and these areas of assessment are actively being evaluated. Industry in most cases will now need to provide specific additional information for assessing the risk of nanomaterials in 3D printing. This review paper focuses on the use of nanomaterials in 3D printing for industrial and manufacturing applications, summarizes the current literature on human health and safety related to 3D printing and inhalation exposure, and the regulations relating to 3D printing in the U.S., Canada, and Europe for this industry.
Collapse
Affiliation(s)
- Alicia A Taylor
- Exponent, Inc., 475 14th Street, Suite 400, Oakland, CA 94612, USA.
| | - Elaine L Freeman
- Exponent, Inc., 1150 Connecticut Avenue NW, Suite 1100, Washington, District of Columbia 20036, USA.
| | - Merel J C van der Ploeg
- Exponent International Ltd., The Lenz, 1st Floor Hornbeam Park, Harrogate, North Yorkshire HG2 8RE, UK.
| |
Collapse
|
6
|
McArdle ME, Freeman EL, Staveley JP, Ortego LS, Coady KK, Weltje L, Weyers A, Wheeler JR, Bone AJ. Critical Review of Read-Across Potential in Testing for Endocrine-Related Effects in Vertebrate Ecological Receptors. Environ Toxicol Chem 2020; 39:739-753. [PMID: 32030793 PMCID: PMC7154679 DOI: 10.1002/etc.4682] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2019] [Revised: 12/01/2019] [Accepted: 02/03/2020] [Indexed: 05/21/2023]
Abstract
Recent regulatory testing programs have been designed to evaluate whether a chemical has the potential to interact with the endocrine system and could cause adverse effects. Some endocrine pathways are highly conserved among vertebrates, providing a potential to extrapolate data generated for one vertebrate taxonomic group to others (i.e., biological read-across). To assess the potential for biological read-across, we reviewed tools and approaches that support species extrapolation for fish, amphibians, birds, and reptiles. For each of the estrogen, androgen, thyroid, and steroidogenesis (EATS) pathways, we considered the pathway conservation across species and the responses of endocrine-sensitive endpoints. The available data show a high degree of confidence in the conservation of the hypothalamus-pituitary-gonadal axis between fish and mammals and the hypothalamus-pituitary-thyroid axis between amphibians and mammals. Comparatively, there is less empirical evidence for the conservation of other EATS pathways between other taxonomic groups, but this may be due to limited data. Although more information on sensitive pathways and endpoints would be useful, current developments in the use of molecular target sequencing similarity tools and thoughtful application of the adverse outcome pathway concept show promise for further advancement of read-across approaches for testing EATS pathways in vertebrate ecological receptors. Environ Toxicol Chem 2020;39:739-753. © 2020 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals, Inc. on behalf of SETAC.
Collapse
Affiliation(s)
| | | | | | - Lisa S. Ortego
- Environmental Safety, Bayer CropScienceChesterfieldMissouriUSA
| | - Katherine K. Coady
- Toxicology and Environmental Research and Consulting, Dow ChemicalMidlandMichiganUSA
| | - Lennart Weltje
- BASF SE, Agricultural Solutions‐EcotoxicologyLimburgerhofGermany
| | - Arnd Weyers
- Crop Science DivisionBayerMonheim am RheinGermany
| | | | - Audrey J. Bone
- Environmental Safety, Bayer CropScienceChesterfieldMissouriUSA
| |
Collapse
|
7
|
Abstract
This review of diagnostic imaging in cases of suspected child abuse characterizes the significant differences between bone scintigraphy and x-ray evaluation, describes the advantages and disadvantages of each modality, postulates on the specific mechanisms of injury that produce the characteristic scintigraphic findings, and emphasizes the influences that scintigraphic studies have on the medical, social, and legal aspects of child abuse. The major advantages of bone scintigraphy are its increased sensitivity (25% to 50%) in detecting evidence of soft tissue as well as bone trauma in child abuse. Furthermore, it is postulated that the specific mechanisms of inflicting the trauma relate to the patient's size and are characterized by bone scintigraphy. During fits of anger or frustration, the perpetrator of child abuse grasps the small infant or child by the thorax during the shaking activity. This produces characteristic rib injuries. The older and heavier child is more likely to be grabbed by the extremities, which produces periosteal injuries manifested as characteristic abnormal localizations in the diaphyses of the extremities. The roentgenograms of these injuries are frequently normal. The importance of bone scintigraphy is its complementary nature in defining and characterizing the extent and severity of trauma from child abuse. Such findings have direct bearing on the medical, social, and legal outcomes for the abused child. The quality of scintigraphic imaging is important, requiring the use of magnification techniques in the infant. The interpretation of the scintigraphic images depends on an understanding of the mechanisms by which the radionuclide localizes in bone. The same traumatic incident can lead to decreased, normal, or increased localization at the trauma site. Radionuclide scintigraphy is a complementary rather than competitive imaging modality to X-ray evaluation in the diagnosis and management of physical child abuse.
Collapse
Affiliation(s)
- J J Conway
- Division of Nuclear Medicine, Children's Memorial Hospital, Chicago, IL 60614
| | | | | | | | | | | | | |
Collapse
|
8
|
|